SpaceX is at $2.2 trillion in valuation after IPO at $135 ($1.75 trillion).
Elon Musk has over $1.1 trillion in net worth.
Brian Wang is a Futurist Thought Leader and a popular Science blogger with 1 million readers per month. His blog Nextbigfuture.com is ranked #1 Science News Blog. It covers many disruptive technology and trends including Space, Robotics, Artificial Intelligence, Medicine, Anti-aging Biotechnology, and Nanotechnology.
Known for identifying cutting edge technologies, he is currently a Co-Founder of a startup and fundraiser for high potential early-stage companies. He is the Head of Research for Allocations for deep technology investments and an Angel Investor at Space Angels.
A frequent speaker at corporations, he has been a TEDx speaker, a Singularity University speaker and guest at numerous interviews for radio and podcasts. He is open to public speaking and advising engagements.
AI business generated loss, but that is because they are building&developing.
1,5 billion a month from Anthropic + 920 mil from Google deal, those are nice numbers. They will be squeezing Altman out of business.
75 billion from IPO for new infrastructure,… nice.
Will longevity-seeking companies end up being an even better investment?
“According to an analysis by Longevity.Technology based on PitchBook data, longevity biotech companies raised approximately $3.74 billion across 49 financing events during the first quarter of 2026, up 56% from the same period a year earlier. The sector is attracting billionaire investors, pharmaceutical partners, and some of the largest funding rounds in biotechnology.”
See:
https://finance.yahoo.com/sectors/healthcare/articles/billionaire-bet-isnt-ai-longevity-130000703.html
&
https://www.yahoo.com/news/science/articles/first-ever-reverse-aging-drug-100002558.html
Longevity investment is hot in one area, partial cellular epigenetic reprogramming. In all other areas it is still quite, despite senolytic treatments having much more data and better recorded effects on longevity in animal models. Reason discussed this at fightaging.org recently:
https://www.fightaging.org/archives/2026/06/a-great-deal-more-funding-for-the-development-of-partial-reprogramming-therapies/
@Brian, I don’t know if you are still reviewing comments, but you should really try to interview Reason (that’s his real name) if you can. He has a very interesting company focused on arterial cholesterol plaque removal.
“arterial cholesterol plaque removal.”
Nanoparticles Therapy Could Wipe Out Plaque Build-Up in Arteries:
https://www.sciencealert.com/nanoparticles-therapy-could-wipe-out-plaque-build-up-in-arteries